Agendia
Callie Laden has a diverse work experience beginning in 2009 at Berry College, where they served as Class President and Institutional Research Manager. Callie then worked at Take Time to Travel as a Business Development Coordinator before joining Primrose Schools. At Primrose, they held roles as Franchise Development Specialist and later as Franchise Development Manager, assisting in franchise growth and marketing campaigns. Following this, they worked as a Business Development Manager at YANMAR America, assisting in sales activities and Salesforce administration. Callie then transitioned to Myriad Genetics as Manager of Commercial Operations. Most recently, Callie Laden held the position of Director of Commercial Operations and Analytics at Strata Oncology before becoming Vice President of Commercial Operations and Strategic Analytics at Agendia in 2023.
Callie Laden attended Berry College from 2009 to 2012. In 2019 and 2021, they obtained various certifications in data analysis, management and leadership, and Google Analytics. In 2022, they completed a Code of Conduct Essentials course.
This person is not in any offices
Agendia
Agendia is the only molecular diagnostics company focused solely on breast cancer. With their groundbreaking genomic testing, they generate reliable and meaningful clinical data about the unique biology of a woman’s breast cancer.